Clinical trial Recruiting at 1 site Observational Ages 18 and up

Analyzing factors affecting pancreatic tumors and cysts

Official title: Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region

Run by Umeå University · NCT05155878 · Data updated 2026-11-12

This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorUmeå University
Academic / other
Locations1 site (Umeå)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedJanuary 1, 2035
Study endsJanuary 1, 2040
Registry record updatedJanuary 5, 2022
Trial IDNCT05155878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients recommended for surgery due to tumors or cysts in the pancreas or periampullary region.

Probably not a fit

Patients who are not able to provide informed consent and are still alive at the study initiation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze prognostic and predictive factors related to the diagnosis and surgical treatment of cysts and tumors in the pancreas and periampullary region. Participants will be enrolled both prospectively and retrospectively, allowing for a comprehensive examination of clinical outcomes based on patient and tumor characteristics. The study will utilize clinical data along with blood and tissue samples to develop and validate biomarkers that could enhance treatment strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment approaches for patients with pancreatic tumors and cysts.

How similar studies have gone: While similar studies have explored prognostic factors in pancreatic conditions, this specific approach focusing on biomarker development is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Recommended surgery for tumor or cyst in the pancreas or periampullary region
* Information avalible in electronic journal files
* Informed consent (or deceased for retrospective part of the study)

Exclusion Criteria:

* No informed consent (and still alive at study initiation)

Where it's running

  • Surgical Clinic at Umeå University Hospital
    Umeå, Sweden
    Recruiting

Study contacts

  • Principal investigator: Oskar Franklin, MD/PhD — University Hospital, Umeå
  • Study coordinator: Oskar Franklin, MD/PhD
  • Email: oskar.franklin@umu.se
  • Phone: +4690785000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.